Equine Sports Council
Controlled Medications,  Sanctioning Network

Understanding Dexamethasone in the Show Ring: Balancing Medical Care with Competition Integrity

PALMETTO, FLA – For equine competitors and managers, navigating the medicine cabinet requires a careful balance between your horse’s health and the rules of the show ring. Dexamethasone (often called “Dex”) is a highly effective corticosteroid widely used by veterinarians to manage severe inflammation, allergies, and respiratory issues. [, 2, 3]

While it is a valuable therapeutic tool, combining dexamethasone with other medications can significantly alter how it acts inside the horse. Understanding the physiological synergy, health considerations, and withdrawal guidelines is essential for keeping your horse safe and your record clear at Equine Sports Council (ESC) events. [1, 2, 3]

The Medical Exception: Medication Reports and Veterinary Oversight

At ESC events, the focus is on horse welfare and fair play. This means that while certain therapeutic medications are allowed to ensure a horse’s comfort, their use must be transparent. [1, 3]

Veterinarians may elect to use dexamethasone to treat legitimate medical conditions. However, to maintain transparency, exhibitors must submit an official ESC Medication Report. This report must be filed by the agent and outline: [1, 2, 3, 4]

  • The specific veterinary diagnosis
  • The therapeutic plan
  • The steps taken to avoid health risks during competition [1, 2]

Transparency ensures that horses receive the care they need without compromising the integrity of the sport. []

Combining Dex with NSAIDs: A Class-Wide High-Risk Zone

When discussing the risks of combining dexamethasone with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), it is a common misconception that the warnings only apply to Bute (phenylbutazone) and Banamine (flunixin meglumine). The restriction and high-risk warning apply to the entire NSAID class without exception. [1, 2, 3, 4]

Under the ESC Controlled Medication database, classical NSAIDs are grouped as Class A therapies. While the ESC allows single-dose management of individual NSAIDs under strict timing windows, combining any NSAID with a heavy corticosteroid like dexamethasone multiplies systemic dangers: [, 2, 3, 4]

  • The Health Risks: Both corticosteroids and NSAIDs work by blocking prostaglandins. However, these same prostaglandins stimulate the protective mucus lining of the stomach and maintain blood flow to the kidneys. Stacking dexamethasone with any NSAID completely strips away these protective mechanisms, which can lead to rapid gastric ulceration, severe protein loss, right dorsal colitis, and acute kidney stress. [1, 2, 3]
  • The Full NSAID List: This critical health risk exists whether you use traditional options like Bute and Banamine, newer options like Ketoprofen, or even daily COX-2 selective options like Equioxx (firocoxib). It also applies to systemically absorbed topical NSAID creams like Surpass (diclofenac). [, 2, 3]
  • Performance Attributes: Stacking these medications creates a profound masking effect on musculoskeletal pain. It can allow a horse to perform well beyond its natural physical comfort threshold, increasing the risk of severe, hidden injury during competition. There is no valid medical or competitive reason to utilize these therapies concurrently at a show. [1]

Combining Dex with Respiratory Medications: The Synergy Effect

When horses suffer from environmental allergies or equine asthma, veterinarians frequently look to respiratory aids like Clenbuterol and Albuterol, or antihistamines like Trihist (triple antihistamine).

Clenbuterol & Albuterol (Bronchodilators)

  • The Synergy: Dexamethasone has a unique chemical relationship with clenbuterol and albuterol. Continuous use of these bronchodilators can cause the horse’s lung receptors to become desensitized, making the medication less effective over time. Dexamethasone actually resets and protects these receptors, forcing the lungs to remain wide open and highly responsive.
  • Performance Attributes: Because this combination dramatically clears the airways and maximizes lung capacity, it provides a distinct stamina and breathing advantage. Furthermore, clenbuterol can have a repartitioning effect that influences muscle tone.
  • The Withdrawal Strategy: While standard protocol allows for a 12-hour withdrawal period for dexamethasone alone, a significantly longer withdrawal period should be used if it was combined with clenbuterol or albuterol. Because Dex amplifies and extends the performance-altering effects of these respiratory medications, a standard 12-hour window is not sufficient to ensure a level playing field.

Trihist (Antihistamines)

  • Health & Performance: Pairing Dex with an antihistamine like Trihist tackles systemic allergies from two different angles. However, antihistamines can cause mild drowsiness or altered mental focus, which can affect a horse’s performance style and responsiveness in the ring.

Guidelines for ESC Competitors

To ensure your horse is healthy and your entries remain compliant, keep these core principles in mind:

  1. Observe the 12-Hour Rule: Dexamethasone requires a minimum 12-hour withdrawal period prior to competition when used as a standalone treatment.
  2. Extend for Combinations: If your horse has received Dex alongside clenbuterol or other respiratory medications, consult your veterinarian to establish a much longer, safer withdrawal cushion. [1]
  3. File Your Paperwork: Always have your veterinarian submit an ESC Medication Report detailing the diagnosis whenever controlled therapeutic medications are required close to show time. [1, 2]

By understanding the science behind these medications, we can protect our horses’ long-term health while keeping the competition fair and rewarding for everyone. []

Co-Founder, Managing Director

error: Content protected